255 related articles for article (PubMed ID: 18267277)
1. Ultrasound in the (premotor) diagnosis of Parkinson's disease.
Berg D
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S429-33. PubMed ID: 18267277
[TBL] [Abstract][Full Text] [Related]
2. Early diagnosis of Parkinson's disease.
Gaenslen A; Berg D
Int Rev Neurobiol; 2010; 90():81-92. PubMed ID: 20692495
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
4. Place value of transcranial sonography in early diagnosis of Parkinson's disease.
Berg D; Gaenslen A
Neurodegener Dis; 2010; 7(5):291-9. PubMed ID: 20616564
[TBL] [Abstract][Full Text] [Related]
5. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
Walter U
Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
[TBL] [Abstract][Full Text] [Related]
6. Transcranial ultrasound as a risk marker for Parkinson's disease.
Berg D
Mov Disord; 2009; 24 Suppl 2():S677-83. PubMed ID: 19877199
[TBL] [Abstract][Full Text] [Related]
7. Transcranial sonography in the premotor diagnosis of Parkinson's disease.
Behnke S; Schröder U; Berg D
Int Rev Neurobiol; 2010; 90():93-106. PubMed ID: 20692496
[TBL] [Abstract][Full Text] [Related]
8. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
Berg D
J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077
[TBL] [Abstract][Full Text] [Related]
9. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
Berg D
J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
[TBL] [Abstract][Full Text] [Related]
10. Transcranial brain sonography for Parkinsonian syndromes.
Bor-Seng-Shu E; Paschoal FM; Almeida KJ; De Lima Oliveira M; Nogueira RC; Teixeira MJ; Walter U
J Neurosurg Sci; 2019 Aug; 63(4):441-449. PubMed ID: 31210040
[TBL] [Abstract][Full Text] [Related]
11. Predicting Parkinson's disease - why, when, and how?
Postuma RB; Montplaisir J
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S105-9. PubMed ID: 20082967
[TBL] [Abstract][Full Text] [Related]
12. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
Miwa H
Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
[TBL] [Abstract][Full Text] [Related]
14. When does Parkinson's disease begin?
Gaig C; Tolosa E
Mov Disord; 2009; 24 Suppl 2():S656-64. PubMed ID: 19877243
[TBL] [Abstract][Full Text] [Related]
15. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
[TBL] [Abstract][Full Text] [Related]
16. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].
Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS
Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340
[TBL] [Abstract][Full Text] [Related]
17. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE
Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498
[TBL] [Abstract][Full Text] [Related]
18. Transcranial sonography (TCS) in Parkinson's disease (PD) and essential tremor (ET) in relation with putative premotor symptoms of PD.
Kim JS; Oh YS; Kim YI; Koo JS; Yang DW; Lee KS
Arch Gerontol Geriatr; 2012; 54(3):e436-9. PubMed ID: 22277379
[TBL] [Abstract][Full Text] [Related]
19. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging: current role in detecting pre-motor Parkinson's disease.
Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K
Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
